Web Analytics
Join WITI Today!

arrowBoston HOME







Member Login



I forgot my password

Join WITI Today!

WITI Boston Regional Network
IT & BioTech-BioScience: What's the Future for Women? -- Sponsored By: Silicon Valley Bank

Monday, November 14, 2005
6:00 p.m - 8:00 p.m.

What is the future of work in this sector and how can women participate? The bio Tech and bioscience industry has been growing in the New England area in recent years creating opportunities for women in IT, HR, Science, management and for entrepreneurs.

Come find out from our panel of experts what the future has in store.

About Our Speaker(s)

Laura Scott
Senior Relationship Manager
Silicon Valley Bank

Laura joined Silicon Valley Bank in 1999 as a Relationship Manager in the Life Sciences Practice. Currently Laura is responsible for leading the business development and portfolio management efforts of one of the Bank’s technology teams focused on software and services, electronic systems and communications.

Laura has over 19 years of commercial banking experience and prior to joining SVB Laura was a Commercial Loan Officer at Flagship Bank & Trust Company and held management positions at Fleet Real Estate Capital, Recoll Management Corp and at Bank of New England.

Laura holds a BA from Tufts University and an MBA from Boston University.

Dr. Maggie Flanagan
Maggie has been in the bio-pharmaceutical industry for 20 years, working in pharmaceutical and biotech companies, holding business development, management and technical roles. Since joining AstraZeneca in 2001, Maggie has been the Global Alliance Director for Global Sciences and Information (formerly Enabling Science and Technology), where she leads an international group responsible for supporting evaluation, negotiation and management of GSI and Global technology platform collaborations. In 2004, Maggie and her group assumed the additional responsibility for supporting the Global Safety Assessment collaboration portfolio. Prior to 2001, Maggie held business development and scientific management positions at Hybridon, Inc.; Oncogene Science Inc.; and Merrell Dow Pharmaceuticals. Originally trained as a biophysical chemist, with a B.S. in Chemistry from the University of Kansas, and a Ph.D. in Physical Chemistry from Indiana University, she trained in molecular and cellular biology as a post-doctoral fellow at the National Institutes of Health.

Maggie O'Toole
Pervasis Therapeutics
A biotech start-up developing cell-based devices that induce repair and healing of blood vessels is where Maggie heads up the office operations. The company’s endothelial cell devices can treat vascular dysfunction and disruption across a broad range of important indications including peripheral and coronary artery disease.

Maggie began her career in marketing and business management for a small government contractor in Virginia where she became intricately involved in the proposal development process. Moving to Boston she focused her interests in marketing and management to that of high-tech start-ups in the Cambridge area. Brought on to Pervasis as the third employee, Maggie works directly with the President and is responsible for the office management of this fast growing biotech. Her responsibilities range from overseeing the build out of new office and lab space in Kendall Square, to establishing the company infrastructure in regards to HR and Finance alongside the CFO. Maggie works with various consultants to manage the website and assist in the development of corporate branding.

Maggie earned her Bachelors in Literary and Cultural Studies from Carnegie Mellon University.

Jean Qiu, PhD
Nexcelom Bioscience, LLC
Jean Qiu, founder of Nexcelom Bioscience LLC, a provider of innovative products for life science research and diagnostics. The combination of micro- and nano-structured polymer film, optical instrument, data analysis software provides a unique solution to automate routine tasks for biologists engaged in disease research and drug discovery.

Jean gained her experience in product development and commercialization from 3M Company, where she did basic research, developed products, and led cross-functional commercialization teams. She was a winner of the Rank Prize of Optoelectronics in 1993 for a breakthrough in semiconductor laser technology. Jean has numerous technical publications and holds more than 12 US patents.

Prior to starting Nexcelom Bioscience, Jean worked for SRU Biosystems, a biotechnology start-up company, as director of process development and manufacturing, where she was instrumental in developing a novel biosensor technology into manufacturable products.

Jean earned her PhD from the School of Electrical Engineering at Purdue University.

Joan Wood, Vice President Workforce Development
Genzyme Corporation
Joan is responsible for the overall development of Genzyme Corporation’s global biotechnology workforce. Her focus is in the areas of management and leadership development, and organizational development, diversity and college relations. Programs under her direction include Genzyme's Mobilizing Talent initiative, and Genzyme's MBA Management Development and Summer Internship Programs. Through these programs Genzyme recruits graduate level and business school students at select institutions to join Genzyme in short-term summer positions during their graduate programs, and for regular full-time positions upon completion of their graduate degrees.

Previously, Joan was Senior Vice President at Scudder Investments, where she led the Learning and Development function for Scudder's U.S. Mutual Fund Group and oversaw customer education for the AARP family of funds. Joan also previously was Director of Curriculum Development for Service Delivery University at Fidelity Investments. Joan's current special interest is in executive coaching, particularly in the areas of visionary and metaphoric thinking and conflict resolution. She has served as a speaker at international HR conferences for the past five years.

Event Date and Venue

This event will be held from 6:00 p.m - 8:00 p.m. on Monday, November 14, 2005 at:

    Silicon Valley Bank
    One Newton Executive Park, Suite 200
    Newton, Massachusetts 02462

6:00 PM - Registration, Networking & Hors d'Oeuvres, Beverages
6:45 PM - Announcements & Introductions
7:00 PM - Panel Discussion
7:45 PM - Q & A
8:00 PM - Adjournment


Pre-registration for this event is closed and on-site registrations will not be accepted.

About Our Sponsor(s)

Silicon Valley Bank provides diversified financial services to emerging growth and mature companies in the technology, life science, private equity and premium wine markets. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, Silicon Valley Bank provides a level of service and partnership that measurably impacts its clients' success.

Headquartered in Santa Clara, Calif., the company offers its clients financial products and services including commercial, investment, merchant and private banking, and private equity services, as well as value-add services using its knowledge and networks. Merger, acquisition, private placement and corporate partnering services are provided through the company's investment banking affiliate, SVB Alliant. Founded in 1983, the company serves nearly 10,000 clients around the world through 27 domestic offices, two international subsidiaries in the U.K. and India, and an extensive network of relationships with venture capitalists in Asia, Australia, Europe, India, and Israel.

With solid understanding of the true risks and rewards faced by companies in dynamic markets, the company is widely recognized for its ability to develop innovative approaches to meet the unique financial needs of its clients. Silicon Valley Bank began serving the technology and life science markets at a time when they were not well-understood by the financial services industry and when many of the leading companies in these industries were just getting started. At that time, many of these companies had yet to show profits and were not considered creditworthy by local community or regional banks.

Over the last two decades, Silicon Valley Bank has become one of the most respected names in the financial services industry. The company has created innovative solutions for some of the world's most successful technology and life sciences companies. These companies face unique challenges and require special services, such as finding the right venture capitalist or angel investor, securing capital to support rapid growth, or driving overseas expansion. Silicon Valley Bank offers products and services specifically tailored to meet our clients' needs at every stage of corporate growth.

Today, Silicon Valley Bank has over 1,000 employees and over $4 billion in assets. The company operates offices throughout Silicon Valley in Fremont, Menlo Park, Santa Clara (2) and Palo Alto (3), California -- the center of the venture capital community in California. Other regional offices within California include Irvine, Los Angeles, Napa, San Diego, San Francisco, and Sonoma. Across the country, Silicon Valley Bank operates locally in Phoenix, Arizona; Boulder, Colorado; Atlanta, Georgia; Chicago, Illinois; Boston, Massachusetts; Minneapolis, Minnesota; New York, New York; Durham, North Carolina; Portland, Oregon; Philadelphia, Pennsylvania; Austin, Texas; Dallas, Texas; Reston, Virginia; and Seattle, Washington. International subsidiaries are located in London and Bangalore. More information on Silicon Valley Bank can be found at www.svb.com.

Contact Us

For more info regarding registration or event details, please contact Jo-An Thomas, WITI New England Regional Vice President ([email protected]).

For more details about pre-registration, contact Tech Support.